This study is a registry for patients with amblyopia (often called "lazy eye," a condition where one eye has reduced vision) who are using Luminopia. Luminopia is an FDA-approved medical device that uses therapeutic software to help improve vision in the weaker eye. Researchers want to understand how well Luminopia works over time by tracking changes in your vision, how long you use the treatment, and how long the vision improvements last after you stop treatment. To join, you must have an amblyopia diagnosis and have used Luminopia for at least 12 weeks. This is an observational study, meaning researchers will collect information from your regular care, not give you new treatments. The study aims to enroll 500 participants, but its current status is unclear.

Study design

This is an observational study, meaning researchers will collect information from your regular care. It plans to include 500 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your visual acuity will be tracked at 3, 6, 12, and 24 months to see how long the results last after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.